about
Nicotine vaccines for smoking cessationNicotine vaccines for smoking cessationCYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropionThe positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptorsNovel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulationRepetitive Transcranial Magnetic Stimulation (rTMS) in the Management of Alcohol Dependence and other Substance Abuse Disorders - Emerging Data and Clinical Relevance.Anxiolytics for smoking cessation.Pharmacology of nicotine: addiction, smoking-induced disease, and therapeuticsNeurostimulation techniques in the treatment of nicotine dependence: A review.Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung developmentTargeting nicotine addiction: the possibility of a therapeutic vaccine.Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinenceBupropion inhibits the cellular effects of nicotine in the ventral tegmental areaEffect of nicotine on body composition in mice.Varenicline in the treatment of tobacco dependence.Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.Early cannabis use and DSM-IV nicotine dependence: a twin study.Mechanism-based medication development for the treatment of nicotine dependence.Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal.Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessationThe endocannabinoid system: a new molecular target for the treatment of tobacco addiction.Pharmacotherapy for smoking cessation.Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.Economic evaluation of pharmaco- and behavioral therapies for smoking cessation: a critical and systematic review of empirical research.Challenges of treating asthma in people who smoke.Repetitive transcranial magnetic stimulation and drug addiction.Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review.Emerging therapeutic targets for the treatment of nicotine addiction.Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents?
P2860
Q24201422-8ACAB7C8-5708-4544-BA0D-9039FCA2D3C0Q24243661-A20C874D-9A8C-414D-98BD-544E2F0BDB8FQ24634660-843C22F9-1CD7-4398-B9A1-E372C7CF3A2FQ24651488-87A1492D-EF88-433E-BE7C-85383D7F3DFAQ26853630-92F0A7BC-25CF-49ED-A7A0-2F4F1D628508Q30863637-C1017C99-E20E-4E4D-9EB8-F01FED61447EQ34062467-1226099F-13E0-41C4-BC1F-63C7DF988F78Q34157674-C4BF4869-4910-461E-B8A1-73825FB8D59CQ34534847-09E05791-815A-4382-A646-8FA1D7F9AA04Q34874695-C368FBD6-60EF-426F-93E3-F24322EF3041Q34987300-C9A0A6B1-0B5B-4E6B-B1B1-58434A31C21FQ35095077-37276D1D-8B8A-4A5C-BD79-D99C9DFB5563Q35575011-892F75C4-5D00-40BE-876B-343EAA277B00Q36122868-FCC2D369-FBAB-425D-86B7-78CF0D3BBF8BQ36239552-4E3E2182-E277-4FE7-937E-266CFB9285EEQ36842193-481132A1-DA63-4244-97C1-EB18F9889E6FQ36945634-16460C68-D9C6-4729-96AC-FA5DD896EF77Q37000693-99075C87-90B6-447B-89A7-51E049C1EB5DQ37018610-45B7A437-8D6D-4F9A-8655-61C7494FB7D3Q37163861-1C88C7C3-3AC6-4F6B-B0BC-431B29A758A9Q37189749-24B45A2F-7909-4BD7-9E0D-B045290F2947Q37291517-C817C3A0-2E41-485B-ADA2-E34E8B366CE7Q37362638-D997A41D-0E74-49DB-8A79-E5C64A6B01EFQ37586662-D905FDD8-88E6-476E-AFF7-9523A63A4F25Q37648843-62C54B8B-DB5D-46B4-9FE3-F1B4C644F4E7Q37733518-732DF232-6ADF-45E9-9DF3-B45E69123721Q37971401-9E5112D4-A3CD-454D-BC20-350BC6ADAC64Q37981714-2B59BF4E-30AF-49FC-8214-20B4C623BFF2Q38473341-62152CE1-7774-4B93-9AFF-3377653ADB05Q42030954-845EB270-9E67-4230-BA2F-5E021FD1569EQ50161791-A79B01D2-2C46-4756-BA02-1C547913F24E
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Non-nicotinic therapies for smoking cessation.
@ast
Non-nicotinic therapies for smoking cessation.
@en
Non-nicotinic therapies for smoking cessation.
@nl
type
label
Non-nicotinic therapies for smoking cessation.
@ast
Non-nicotinic therapies for smoking cessation.
@en
Non-nicotinic therapies for smoking cessation.
@nl
prefLabel
Non-nicotinic therapies for smoking cessation.
@ast
Non-nicotinic therapies for smoking cessation.
@en
Non-nicotinic therapies for smoking cessation.
@nl
P1476
Non-nicotinic therapies for smoking cessation
@en
P2093
Eric C K Siu
P304
P356
10.1146/ANNUREV.PHARMTOX.47.120505.105354
P577
2007-01-01T00:00:00Z